2020
DOI: 10.1080/21691401.2020.1770264
|View full text |Cite
|
Sign up to set email alerts
|

Identification of potential key pathways, genes and circulating markers in the development of intracranial aneurysm based on weighted gene co-expression network analysis

Abstract: Duysenbi (2020) Identification of potential key pathways, genes and circulating markers in the development of intracranial aneurysm based on weighted gene coexpression network analysis,

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 41 publications
(41 reference statements)
0
4
0
Order By: Relevance
“…Although such efforts are of great value, they do not assay the aneurysm tissue specifically for the local gene expression alterations. Small series have described the gene expression profiles from the aneurysmal domes collected as part of clipping ( 35 , 40 , 41 ); however, this type of assay is not possible for those aneurysms not amenable to open surgical treatment (similar to most fusiform vertebrobasilar aneurysms). With this manuscript, we advance the concept of endovascular biopsy and scRNAseq as a next step toward a precision medicine approach to neurovascular disease.…”
Section: Discussionmentioning
confidence: 99%
“…Although such efforts are of great value, they do not assay the aneurysm tissue specifically for the local gene expression alterations. Small series have described the gene expression profiles from the aneurysmal domes collected as part of clipping ( 35 , 40 , 41 ); however, this type of assay is not possible for those aneurysms not amenable to open surgical treatment (similar to most fusiform vertebrobasilar aneurysms). With this manuscript, we advance the concept of endovascular biopsy and scRNAseq as a next step toward a precision medicine approach to neurovascular disease.…”
Section: Discussionmentioning
confidence: 99%
“…Along with the development of bioinformatic tools appeared a new type of study presenting re-analyzed data from available datasets, including expression data from the Gene Expression Omnibus (GEO). Approximately one third of these published secondary analyses utilized a single dataset [ 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 ] and two thirds leveraged data from two to eight datasets [ 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 ]. These studies did not provide any new additional clinical data but rather aimed to deepen the insight into molecular mechanisms of the IA pathophysiology by revealing key regulatory networks and interactions between investigated molecules.…”
Section: Studies Based On Existing Datasetsmentioning
confidence: 99%
“…Intracranial aneurysm (IA) is a potentially devastating cerebrovascular disease characterized by the pathological dilatation of the intracerebral arterial wall to form a cystic bulge [1]. Unruptured IAs (UIAs) occur in middle-aged and elderly people in the 40-60 age group, with a prevalence of up to 3.2% [2]. A majority of patients with UIAs often have no obvious clinical manifestations and are diagnosed on examination.…”
Section: Introductionmentioning
confidence: 99%
“…However, some patients are still admitted to the hospital as an emergency with IA rupture leading to subarachnoid hemorrhage. Aneurysm rupture occurs in approximately 1% of patients with IA each year [3], resulting in a mortality rate of 30-40% and a disability rate of approximately 50% among survivors [2]. The prognosis is often poor.…”
Section: Introductionmentioning
confidence: 99%